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Abstract
Background: We have investigated a simple strategy for enhancing transgene expression specificity by leveraging
genetic silencer elements. The approach serves to restrict transgene expression to a tissue of interest - the nervous
system in the example provided here - thereby promoting specific/exclusive targeting of discrete cellular subtypes.
Recent innovations are bringing us closer to understanding how the brain is organized, how neural circuits
function, and how neurons can be regenerated. Fluorescent proteins enable mapping of the ‘connectome’,
optogenetic tools allow excitable cells to be short-circuited or hyperactivated, and targeted ablation of neuronal
subtypes facilitates investigations of circuit function and neuronal regeneration. Optimally, such toolsets need to be
expressed solely within the cell types of interest as off-site expression makes establishing causal relationships
difficult. To address this, we have exploited a gene ‘silencing’ system that promotes neuronal specificity by
repressing expression in non-neural tissues. This methodology solves non-specific background issues that plague
large-scale enhancer trap efforts and may provide a means of leveraging promoters/enhancers that otherwise
express too broadly to be of value for in vivo manipulations.
Results: We show that a conserved neuron-restrictive silencer element (NRSE) can function to restrict transgene
expression to the nervous system. The neuron-restrictive silencing factor/repressor element 1 silencing transcription
factor (NRSF/REST) transcriptional repressor binds NRSE/repressor element 1 (RE1) sites and silences gene
expression in non-neuronal cells. Inserting NRSE sites into transgenes strongly biased expression to neural tissues.
NRSE sequences were effective in restricting expression of bipartite Gal4-based ‘driver’ transgenes within the
context of an enhancer trap and when associated with a defined promoter and enhancer. However, NRSE
sequences did not serve to restrict expression of an upstream activating sequence (UAS)-based reporter/effector
transgene when associated solely with the UAS element. Morpholino knockdown assays showed that NRSF/REST
expression is required for NRSE-based transgene silencing.
Conclusions: Our findings demonstrate that the addition of NRSE sequences to transgenes can provide useful new
tools for functional studies of the nervous system. However, the general approach may be more broadly
applicable; tissue-specific silencer elements are operable in tissues other than the nervous system, suggesting this
approach can be similarly applied to other paradigms. Thus, creating synthetic associations between endogenous
regulatory elements and tissue-specific silencers may facilitate targeting of cellular subtypes for which defined
promoters/enhancers are lacking.
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Background
Accurate characterization of neurons and neural circuits
requires that neuronal subtypes be unambiguously identi-
fied [1] and independently manipulated [2]. Typically, neu-
rons are classified based on morphological (e.g., neurite
targeting patterns), molecular (e.g., transmitter expression)
and/or physiological properties. Cellular subtypes are
defined by both activation and repression of specific gene
sets. Repression plays a major role in regulating the
expression of neural-specific genes. For instance, the tran-
scriptional repressor neuron-restrictive silencing factor
(NRSF)/repressor element 1 silencing transcription factor
(REST) serves to silence neural gene expression in non-
neural tissues [3,4]. Transgenic techniques provide a
means of targeting discrete neuronal subpopulations,
affording investigations of the function of specific neuronal
cell types and neural subcircuits [5,6]. However, transgenic
labeling of neuronal subpopulations in vertebrates has pro-
ven to be complicated, as cis-regulatory elements (e.g.,
promoters, enhancers) that delineate specific neuronal
subtypes are sometimes difficult to define. Equally proble-
matic is that many regulatory elements characterized as
being cell-type specific within the nervous system actually
label cells in other tissues. Optimally, exclusive transgene
expression in neuronal cell subtypes is necessary to assign
direct causal effects during assays involving gain- or loss-
of-function manipulations.
Gene and/or enhancer trap screens, whereby endogen-
ous cis-regulatory elements are co-opted to regulate trans-
gene expression, eliminate the need to identify cell-specific
promoters by allowing visual selection of expression pat-
terns of interest. Transposons, such as Tol2, have been
used extensively for gene/enhancer trapping in zebrafish
(Danio rerio) and many of the resultant transgenic lines
show expression in the nervous system. However, despite
the general success of this approach, so-called basal or
background expression in heart, skeletal muscle, etc., can
compromise the usefulness of these resources [7]. This has
been particularly problematic for enhancer traps employ-
ing the Gal4/upstream activating sequence (UAS) bipartite
expression amplification system [8-10]. The Gal4/UAS
system is based on the yeast transcription factor Gal4,
which binds to 17 to 23 bp UAS [11] to drive expression
of effector genes/transgenes. A bipartite transgenic system,
where Gal4 ‘drivers’ and UAS ‘effectors’ are derived sepa-
rately was adapted to the Drosophila system [12] as a tis-
sue/cell-specific manipulation platform. Rapid expansion
of a set of Gal4 driver lines (specifying where and when
transgenes are expressed) and UAS effector/reporter
transgenic lines (specifying how much and what trans-
genes are expressed) soon followed. Driver and effector/
reporter lines can be brought together in any combination;
the bipartite nature of the Gal4/UAS system thus provides
a versatile platform for studies of cell and molecular
function that has been employed to great effect within the
Drosophila community [13]. The source of background
expression in zebrafish Gal4/UAS-based transgenic lines
has not been resolved. It could be a byproduct of cryptic
enhancer elements [8], promiscuous expression as a result
of position effects, or otherwise undetectable gene expres-
sion that is revealed by the enhanced transcriptional activ-
ity of the Gal4/UAS system. The latter possibility is in
keeping with interpretations put forth by Fujimoto et al.
[14], concerning unexpected expression patterns seen in
Gal4-VP16 lines (three of three Tg(optb.A:Gal4-VP16)
lines show previously uncharacterized expression within
eye muscles and retinal cells). Regardless of the underlying
mechanism, Gal4/UAS lines in which background expres-
sion is reduced or eliminated would provide improved
resources for functional studies of the nervous system.
Intersectional and subtractive methods, whereby trans-
genes are restricted to cells expressing two or more pattern-
ing genes, have been developed to promote cell-specific
expression [15]. Alternatively, transcriptional repression or
silencing could be used to delimit transgene expression to
specific cell or tissue types. Interestingly, transcriptional
repression plays a prominent role in establishing neuronal
specific expression patterns [16]. Accordingly, we were
interested in determining whether inserting neuronal silen-
cer binding sites into Gal4 driver and/or UAS effector
transgenes would serve to restrict transgene expression to
the nervous system in vivo. This approach could potentially
solve Tol2-associated background expression issues with
regard to studies of the nervous system in zebrafish. More-
over, synthetic associations between endogenous regulatory
elements and tissue-specific silencers may facilitate useful
expression patterns not otherwise attainable by standard
promoter/enhancer characterizations. Here, we have
explored the use of the neuron-restrictive silencer element
(NRSE) to delimit transgene expression exclusively to neu-
ronal cells.
Evaluation of regulatory mechanisms underlying neural
specificity of the synaptic protein stathmin-like 2 gene
(STMN2, also known as SCG10) and a voltage-depen-
dent sodium channel revealed that active repression of
expression in non-neuronal cells played a central role
[17-19]. An NRSE [20] - also known as restriction ele-
ment 1 (RE1 [21]) - was identified as being necessary and
sufficient for repression of STMN2 and the type II
sodium channel. Subsequently, the Krüppel zinc finger
protein NRSF/REST was found to bind NRSE/RE1 sites
and repress non-neuronal expression of multiple neural-
specific genes [3,4]. Upon binding to NRSE/RE1 sites,
NRSF/REST acts in concert with a corepressor complex
of chromatin remodeling proteins including REST core-
pressor 1 [22], Sin3A [23] and histone/lysine deacetylases
[23,24]. NRSF/REST has been reported to repress target
gene expression in both embryonic and neural stem cells
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[25], whereas corepressors appear to play a role in plasti-
city of expression in mature neurons [26]. Although
NRSE-containing genes can be expressed outside the ner-
vous system - e.g., pancreatic islet cells [27] - and NRSE
sites are thought to act as neuronal enhancers in certain
contexts [28], the predominant effect of NRSE-mediated
gene regulation is to repress the expression of neural
genes in non-neuronal cell types. This suggests that inte-
grating NRSE sites into the regulatory elements of trans-
gene constructs might serve to promote specificity by
delimiting expression to the nervous system. This
approach has shown promise when tested in the context
of defined regulatory elements in cell culture [29], viral
vectors [30,31] and transgenic assays in mammalian sys-
tems [32]. We were interested in whether NRSE sites
would be effective for delimiting transgene expression to
the nervous system within the context of enhancer trap
screens in zebrafish, and thereby provide improved
resources for functional studies of the nervous system.
To test this idea, we integrated a pair of consensus
NRSE sites [33] into several bipartite transgenic expression
system constructs and created corresponding transgenic
zebrafish lines. The NRSE site used, TTCAGCACCACG-
GACAGCGCC, is a canonical NRSE site that is highly
conserved across species, and is composed of two non-
palindromic half-sites separated by a non-conserved 2 bp
spacer (underlined). We placed a tandem set of NRSE
sites in upstream regulatory regions of several transgenic
constructs and compared resulting expression patterns to
non-NRSE parental plasmids. In all, this strategy was
applied within the context of enhancer trap constructs
[34], defined enhancer constructs [35], defined promoter
constructs [36] and UAS-based reporter constructs [37].
The data indicate that transgene expression was strongly
biased to the nervous system when NRSE sequences were
included in enhancer trap and defined enhancer con-
structs, thereby effective in delimiting the expression of
the driver element of a bipartite expression system (e.g.,
Gal4-VP16). However, expression biases were not evident
when NRSE sequences were added to UAS-based reporter
transgenes. Nevertheless, due to the bipartite nature of
such systems, delimiting the expression of Gal4-VP16 dri-
vers sufficed to restrict UAS reporters to the nervous sys-
tem as well - because drivers are required to activate
expression of reporters. Morpholino knockdown (this
study) and zinc finger nuclease mediated gene disruptions
[38] verified that NRSF/REST is required for NRSE-based
transgene silencing. Thus, NRSE-delimited transgenesis
may help to overcome difficulties in defining cell-specific
expression in the nervous system. Accordingly, we are
conducting a large-scale enhancer trap screen coupling
NRSE sites with bipartite expression systems to facilitate
functional manipulations of trapped neuronal cell sub-
types. Several other tissue/cell-specific silencer elements
have been reported. Examples include a cartilage-specific
element [39], a cardiac muscle-specific element [40] and a
cell-specific pancreatic silencer element [41]. Thus, trans-
genes that create novel associations between tissue-specific
silencers and more diffusely expressed activator elements
may be a useful strategy for labeling and manipulating dis-
crete cell types that are otherwise difficult to demarcate.
The existence of tissue-specific silencers in plants [42]
suggests such elements exist throughout most multicellu-
lar life forms. In summary, silencer-delimited transgenesis
may be a broadly applicable strategy that enhances the
capacity to exclusively target specific cell types.
Results
NRSE-delimited enhancer traps
To test whether associating NRSE sites with a minimal
promoter would serve to restrict transgene expression to
the nervous system, Gal4-VP16-based enhancer trap con-
structs were assembled with and without NRSE sites.
Plasmids were composed of a mouse cfos minimal pro-
moter [34] upstream of an optimized Gal4-VP16 tran-
scriptional activator, termed KalTA4 [43], and assembled
within the miniTol2 cassette [44]. Initially, transient
transgenesis assays were used to compare control plas-
mids (CK, cfos:KalTA4; see construct diagrams in Addi-
tional file 1) and test plasmids having a tandem repeat of
two NRSE sites inserted 18 bp upstream of the minimal
promoter (NRCK, 2xNRSE-cfos:KalTA4). CK or NRCK
transgenes were injected into fertilized eggs from an
established UAS effector-reporter line, (14xNTR-Ch, Tg
(14xUAS-E1b:nfsB-mCherry)c264 [45]) and resulting
mCherry expression patterns monitored daily until 6 to
7 days post-fertilization (dpf). These preliminary results
suggested that the NRSE-containing plasmid, NRCK, was
preferentially expressed in neural tissues (data not
shown). Following these studies, we created multicistro-
nic ‘self-reporting’ enhancer trap constructs linking
the Gal4-VP16 driver and UAS reporter directly within a
single transgene (i.e., in cis). In the NRSE version, a loxP
flanked 5xUAS:YFP reporter was placed downstream of
NRCK (NRCK-5xMY, 2xNRSE-cfos:KalTA4, loxP-
5xUAS-E1b:gap43-EFYP-loxP). The control version con-
sisted of the CK driver element upstream of tandem
5xUAS:nfsB effector and 14xUAS:YFP reporter compo-
nents (CK-5xN-14xY, cfos:KalTA4, 5xUAS:Eco.nfsB,
14xUAS:gap43-YFP), as previously reported [46].
To more stringently test the effects of NRSE sites on
transgene expression patterns, CK, NRCK and NRCK-
5xMY plasmids were used to establish a series of stable
enhancer trap lines (Figure 1). Individual plasmids were
injected along with Tol2 transposase mRNA into UAS:
reporter-containing eggs derived either from 14xNTR-Ch
or 5xMY-HMY lines (see below). Reporter-expressing
embryos/larvae were raised to sexual maturity then
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Figure 1 Enhancer trap comparisons ±NRSE. Plasmid diagrams and representative confocal images of Gal4 expressing enhancer trap lines
±NRSE, one CK (A-F) and two types of NRCK (G-L and M-R) lines are shown (6 dpf). (A) CK driver and 5xMY-HMY reporter plasmid diagrams.
(B-F) The majority of CK lines showed expression in multiple tissues (B), with neural expression in regions such as the tectum (C, D, arrows) and
midbrain (C, D, arrowheads) as well as labeling of skeletal muscle (E, F, arrows). (G) NRCK driver and 5xMY-HMY reporter plasmid diagrams. (H-L)
The majority of NRCK lines displayed neuronally restricted expression patterns (H), dense innervation patterns in the skin indicate somatosensory
neuron labeling (H-L, arrows), neuromast innervation is also evident in this line (I, J, arrowheads). (M) NRCK-5xMY plasmid diagram. (N-R) Like
NRCK lines, the majority of NRCK-5xMY ‘self-reporting’ lines displayed neuronally restricted expression. The density of reporter labeling was
typically high with near ubiquitous expression throughout the central nervous system being common (O-R). (S) Quantification of phenotypes
from non-NRSE (-NRSE, blue bars, total of 61 lines) and NRSE-containing enhancer trap lines (+NRSE, red bars, total of 51 lines). Expression
patterns were classified as either neural-restricted (as in H-L and N-R), mixed (as in B-F), or non-neural (example not shown). The data shows a
clear trend toward neuronally restricted expression patterns when NRSE elements are included in enhancer trap transgenes. To evaluate the
significance of this trend, chi-square tests of independence were performed comparing the ±NRSE phenotyping datasets. The results show clear
statistical differences across all lines ±NRSE (values shown in graph) and between matched subsets (CK versus NRCK, c2 = 18.5, P = 9.8e-05;
CK-5xN-14xY versus NRCK-5xMY, c2 = 16.4, P = 2.7e-04). The error bars indicate the standard deviation in phenotype between the two +NRSE
and -NRSE transgenic lines.
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mated to test for germline transmission. Reporter-expres-
sing progeny were raised as filial generation one (F1)
lines. Subsequent propagations were used to separate out
individual lines according to unique and reproducible
expression patterns - i.e., to account for multiple trans-
gene integrations. The total number of enhancer trap
lines generated to date is: 24 CK (Et(cfos:KalTA4)), 25
NRCK (Et(2xNRSE-cfos:KalTA4)) and 26 NRCK-5xMY
(Et(2xNRSE-cfos:KalTA4, 5xUAS-E1b:gap43-YFP)), as
well as 37 CK-5xN-14xY (Et(2xNRSE-cfos:KalTA4,
5xUAS-E1b:nfsB, 14xUAS-E1b:tagYFP)). These lines have
been propagated to the F3 to F5 generation and 93% cur-
rently produce inheritance patterns consistent with a sin-
gle insertion site (at least with regard to visually detectable
integration events). In addition to the data presented here,
we have established a website for the dissemination of
high-resolution imaging data and insertion site sequence
information to the research community [47]. We continue
to generate new data regarding these and related trans-
genic lines and thus plan to expand the data available on
this site on an ongoing basis.
Initial evaluations of transgene expression patterns were
promising. However, we noted that mCherry patterns
often seemed unstable, that is, expression domains would
differ slightly from one generation to the next. It was sub-
sequently reported that the Tg(14xUAS-E1b:nfsB-mCherry)
c264 line is susceptible to methylation-based silencing
[48,49]. To avoid NRSE-independent silencing issues,
which could obviously compromise our expression pattern
analyses, we created a new 5xUAS reporter line expressing
membrane-tagged yellow fluorescent protein (YFP; 5xMY-
HMY, Tg(loxP-5xUAS-E1b:gap43-YFP-loxP, he1a:gap43-
YFP)gmc930, see Additional file 1). Importantly, the
5xMY-HMY (gmc930) line has shown no evidence of
silencing over three generations, possibly due to our inclu-
sion of ‘barrier’ insulator sequences [50] or the reduction
in the number of repetitive UAS elements [49]. Barrier
insulators are thought to function by maintaining histones
of chromatin surrounding the site of transgene integra-
tions in a hyperacetylated state, thereby blocking en-
croachment of heterochromatin [51]. Either way, the
5xMY-HMY line provided an improved resource for
defining expression patterns of CK and NRCK enhancer
trap lines. All subsequent expression analyses were
performed by crossing KalTA4 enhancer trap lines to
5xMY-HMY and/or by creating driver lines directly in
5xMY-HMY fertilized eggs.
Phenotypic characterizations of KalTA4 driver lines at 6
to 7 dpf revealed clear differences between control (CK)
and NRSE-containing (NRCK) expression patterns. CK-
derived lines tended to have mixed expression patterns,
with multiple cell types and tissues labeled (Figure 1A-F,
see Additional file 2 or the web-based database (referenced
above) for more images of CK lines). The CK gmc694 line
provides a typical example, with expression in tectal neu-
rons (Figure 1C, D, arrows), midbrain neurons (Figure 1C,
D, arrowheads) and skeletal muscle (Figure 1E, F, arrows).
By contrast, expression in NRCK lines tended to be
restricted to neural tissues (Figure 1G-L, see Additional
file 2 or the web-based database for more images of
NRCK lines). As an example, the NRCK gmc642 line dis-
plays strong expression in somatosensory neurons. In par-
ticular, expression is seen in the trigeminal ganglion
posterior to the eye (Figure 1H, arrow), cranial sensory
neurons (Figure 1I, J), and Rohon-Beard cells of the spinal
cord (Figure 1K, L). Dense innervation throughout the skin
of the head (arrow in Figure 1I, J, arrowhead denotes inner-
vation of sensory placode) and trunk regions (Figure 1K, L,
from Rohon-Beard cells, arrow) is easily visualized due to
the membrane-tagged YFP reporter. This same trend held
for self-reporting NRCK-5xMY lines (Figure 1M-R). How-
ever, the level of reporter expression tended to be markedly
stronger in NRCK-5xMY self-reporting lines than when
NRCK was crossed to 5xUAS:YFP lines. For instance, the
NRCK-5xMY gmc739 line has near ubiquitous expression
throughout the central nervous system, as seen in the brain
(Figure 1N-P) and spinal cord (Figure 1Q-R). Similar differ-
ences in the level of expression between Gal4-VP16 and
UAS transgenes integrated in cis versus in trans have been
previously observed [43]. The mechanism underlying this
phenomenon is not entirely clear but could be due to
effects that trapped enhancers have on both the cfos and
E1b (i.e., UAS-associated) minimal promoters. By contrast,
non-NRSE self-reporting CK-5xN-14xY controls [46] pro-
duced predominantly mixed expression phenotypes (see
Table 1 for quantification).
To quantify the effect of inserting NRSE sites into enhan-
cer trap transgenes, KalTA4 driver lines were classified
between 6 and 9 dpf as displaying one of three phenotypes:
neural-restricted, mixed and non-neural. The results show
NRSE-containing driver lines (including self-reporting
NRCK-5xMY lines) exhibit a clear bias toward neural-
restricted expression compared with controls (Figure 1S,
Table 1). Of 62 NRSE driver lines evaluated, 66% (41
lines) were classified as having neural-restricted expres-
sion. Conversely, of 69 characterized control lines, only
10% (seven lines) showed a neural-restricted pattern. Lines
showing mixed expression patterns (see Figure 1B-F)
made up 68% of CK controls (47 lines) and 29% of NRSE
drivers (18 lines). Non-neural lines made up 22% of
controls and only 5% of NRSE lines (Table 1). These data
suggest that NRSE sites can have dramatic effects on
transgene expression patterns within the context of endo-
genous enhancer elements trapped by a cfos minimal
promoter. Due to the bipartite nature of the Gal4/UAS
system, NRSE-delimited expression of an optimized Gal4-
VP16 transcriptional activator translated to neural-
restricted expression of a UAS:YFP reporter whether
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Gal4-VP16 and UAS transgenes were in trans (Figure 1G-
L) or cis (Figure 1M-R) orientations.
NRSE-delimited expression of a defined enhancer
To extend our evaluation of NRSE-containing transgenes,
we next turned to a defined enhancer element from the
Islet1 locus, termed CREST1, which had proved proble-
matic for our studies. An 800 bp CREST1 sequence was
previously characterized as an enhancer element sufficient
to direct transgene expression to cranial motor neurons
[35]. We were interested in using CREST1 to generate
transgenic models to study cranial motor neuron regenera-
tion using the nitroreductase-based system of targeted cell
ablation [52-54]. Unfortunately, when CREST1 was
inserted into a self-reporting KalTA4/5xUAS-based con-
struct expressing both tagYFP (Evrogen; Moscow, Russia)
and nitroreductase (i.e., CREST1-cfos:KalTA4, 5xUAS-E1b:
tagYFP-2A-nfsB, C1CK-5xY2N, Figure 2A and Additional
file 1), we found that enhanced expression from the Gal4/
UAS elements resulted in a loss of expression specificity in
stable lines (Figure 2B-F). However, when NRSE sites were
inserted upstream of the CREST1 enhancer (2xNRSE-
CREST1-cfos:KalTA4, 5xUAS-E1b:YFP-2A-nfsB, NRC1CK-
5xY2N, Figure 2G and Additional file 1), cranial motor
neuron-specific expression was restored (Figure 2H-M).
The distinctive projection patterns of branchiomotor neu-
rons of the Vth, VIIth and Xth cranial nerves [55] made it
easy to verify NRSE-delimited expression was specific to
the targeted subpopulations (Figure 2I, J and Additional
file 3). We quantified these results by characterizing all
stable transgenic lines derived with these two constructs as
per the phenotypic criterion established above. The data
showed that inclusion of the NRSE sequences dramatically
improved expression specificity of the previously character-
ized motor neuron enhancer (Figure 2M, Table 1). Of the
11 NRSE-containing CREST1 lines, 82% (nine lines)
showed neural-restricted expression (i.e., neuron-specific
expression), while 18% (two lines) had mixed expression;
no line displayed a non-neural phenotype. Conversely,
non-NRSE lines predominantly displayed mixed expression
(75%, six of eight lines), with one line showing neural-
restricted and another showing non-neural expression.
These data support previous findings and show that
neural-specific expression from a defined enhancer can be
reinforced by including NRSE sites, particularly if the use
of expression amplification systems such as Gal4/UAS
results in a loss of specificity.
NRSE sites fail to restrict UAS transgene expression
patterns
Encouraged by results obtained with KalTA4 driver lines,
we were interested to determine whether NRSE sites could
limit expression of UAS reporter transgenes to the nervous
system. If NRSE sites could be shown to work within the
context of UAS transgenes as well (i.e., when incorporated
near UAS elements), this would serve to restrict effectors/
reporters to the nervous system regardless of the Gal4-
VP16-specified pattern. In turn, this would provide a
means of eliminating the background issues of previously
derived Gal4-VP16 expressing transgenic lines - a possibi-
lity worth exploring given the numerous intriguing neural
expression patterns characterized in previous gene/enhan-
cer traps [8-10]. Accordingly, we constructed two versions
of our 5xUAS:M-YFP core reporter transgene, one without
and one with NRSE sites. The non-NRSE version was the
control construct used to establish the 5xMY-HMY line
used above (see Figure 1 and Additional file 1). The second
transgene contained the tandem NRSE repeat just
upstream of the 5xUAS sequence (2xNRSE-loxP-5xUAS-
E1b:gap43-YFP-loxP, he1a:gap43-YFP, NR5xMY-HMY).
Both were constructed in the miniTol2 vector [44] and
used to establish stable lines identically to the previously
described technique. To test whether the addition of NRSE
sites served to neuronally restrict reporter expression, a
double transgenic CK enhancer trap line (Et(cfos:KalTA4)
gmc680; Tg(14xUAS-E1b:nfsB-mCherry)c264) was crossed
to an NR5xMY-HMY line (Tg(loxP-2xNRSE-5xUAS-E1b:
gap43-YFP-loxP, he1a:gap43-YFP)gmc932) to create triple
transgenic offspring (Figure 3A). The CK-based gmc680
enhancer trap line was derived in the 14xNTR-Ch reporter







CK 8% (2/24) 75% (18/24) 17% (4/24)
CK-5xN-14xY 11% (4/37) 62% (23/37) 27% (10/37)
NRCK 68% (17/25) 28% (7/25) 4% (1/25)
NRCK-5xMY 58% (15/26) 35% (9/26) 8% (2/26)
C1CK-5xY2N 13% (1/8) 75% (6/8) 13% (1/8)
NRC1CK-5xY2N 82% (9/11) 18% (2/11) 0% (0/11)
Totals
- NRSE Tg 10% (7/69) 68% (47/69) 22% (15/69)
+ NRSE Tg 66% (41/62) 29% (18/62) 5% (3/62)
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Figure 2 CREST1-cfos transgene comparisons ±NRSE. Plasmid diagrams and representative confocal images of lines derived with the CREST1-
cfos enhancer-minimal promoter element ±NRSE, one C1CK-5xY2N (A-F) and one NRC1CK-5xY2N (G-M) line is shown (6 dpf). (A) C1CK-5xY2N
plasmid diagram. (B-F) The majority of C1CK-5xY2N lines showed mixed expression patterns (B), with labeling of epidermis, skeletal muscle and
notochord often evident (C-F). (G) NRC1CK-5xY2N plasmid diagram. (H-M) The majority of NRC1CK-5xY2N lines had expression restricted to a
cranial motor neuron subpopulation (H) - the expression pattern originally characterized as CREST1-specified [35] - including cranial nerve X
neurons in the hindbrain (arrows, I, J and L, M) and cranial nerve VII and V neurons in the midbrain (arrowheads, I, J and L, M). Autofluorescence
in the gut is marked by asterisks (I, J). (N) Quantification of phenotypes from non-NRSE (-NRSE, blue bars, total of eight lines) and NRSE-
containing (+NRSE, red bars, total of 11 lines) CREST1-cfos lines; expression patterns were classified as either neural-restricted (as in H-M), mixed
(as in B-F), or non-neural (example not shown). The data shows a clear trend toward neuronally restricted expression patterns when NRSE
elements are included in CREST1-cfos transgenes. A chi-square test of independence showed significant differences between the ±NRSE
phenotyping datasets (values shown in graph).
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Figure 3 UAS reporter comparison ±NRSE. Plasmid diagrams and representative confocal images at 6 dpf of a triple transgenic larva where
Gal4 is driving two reporters ±NRSE, a non-NRSE mCherry reporter line (B-D, 14xNTR-Ch (c264)) and a NRSE-containing YFP reporter line (E-G,
NR5xMY-HMY (gmc932), merged images H-J). (A) CK, 14xNtr-Ch and NR5xMY-HMY plasmid diagrams. (B-D) The control mCherry reporter (non-
NRSE) shows a typical mixed expression pattern with neuronal subsets (C, arrow) and skeletal muscle labeling (D). (E-G) The NRSE-UAS YFP
reporter showed expanded expression in skeletal muscle (compare D and G) and a similar pattern in the brain (F, arrow). Note that
autofluorescence from iridiphores in the eye is also evident in the YFP emission channel. (H-J) Merged image showing that the addition of NRSE
sites to UAS reporter plasmids is not sufficient to restrict reporter expression to the nervous system; i.e., the subset of neurons labeled in the
brain (I, arrow). Presumably due to reduced silencing of the NR5xMY-HMY line, there is actually an expansion of YFP reporter expression
throughout skeletal muscle.
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background and initially characterized as having broad
expression in muscle and in a few sparse neurons within
the tectum and midbrain regions (Figure 3B-D). We rea-
soned that if the NRSE-UAS linkage caused reporters to be
restricted to neurons, then crossing the CK gmc680 enhan-
cer trap line to the NR5xMY-HMY gmc932 line should
result in the YFP reporter being expressed in the subset of
neurons labeled but repressed in muscle. However, we
found that this was not the case (Figure 3E-J). Instead, YFP
was expressed throughout an even wider swath of muscle
cells, as well as labeled neurons (Figure 3F and 3I, arrow).
Similar results were obtained when other enhancer trap
lines were crossed with NR5xMY-HMY reporter lines
(data not shown). Together, these findings suggest that
NRSF/REST binding is not able to disrupt transcriptional
activation resulting from Gal4-VP16 interactions with UAS
elements. Thus, to be effective for Gal4/UAS-based gene/
enhancer trapping, NRSE sites need to restrict Gal4-VP16
expression (i.e., be associated with the minimal promoter
of the driver, not UAS elements of the effector/reporter).
Temporal aspects of NRSE-delimited transgenesis
During the course of these studies, we were interested in
identifying enhancer trap lines that labeled distinct neuro-
nal subtypes. Accordingly, we screened F1 larvae for early
and late stage transgene expression (1 to 5 dpf). In addi-
tion to revealing lines that express reporters only after
terminal neuronal differentiation has begun (3 to 5 dpf),
we also observed that some NRSE-delimited lines exhib-
ited expression in muscle cells early on, which then faded
over time - i.e., a ‘delayed non-neuronal repression’ pheno-
type. The Et(2xNRSE-cfos:KalTA4)gmc607 line provides an
example of this phenomenon (Figure 4). At 4 dpf, neuro-
nal and skeletal muscle expression is evident in this line
(Figure 4A, B, arrows indicate muscle cells). Overlap with
the pan-neuronal labeled line, Tg(elavl3:EGFP)knu3 (for-
merly HuC:GFP [56]) was used to demarcate which
mCherry ‘trapped’ cells are neuronal (Figure 4A, B, arrow-
heads). When the same larvae were imaged three days
later (7 dpf), muscle cell expression had faded, fragment-
ing with time and eventually disappearing (Figure 4C, D,
arrows indicate fragmented cells), while neuronal expres-
sion in the spinal cord and gut was maintained (Figure 4C,
D, arrowheads). As noted above, to ensure that this phe-
notype was not due to NRSE-independent silencing of the
UAS:mCherry reporter line, all KalTA4 driver lines were
re-evaluated by crossing to the 5xUAS:YFP reporter line
(5xMY-HMYgmc930). This analysis showed that the delay
in non-neuronal repression we observed with the Cherry
line was also evident when such lines were crossed with
the YFP reporter line (Figure 4E-H). In keeping with its
longer half-life, the time required for loss of non-neural
expression of YFP was extended in some cases (e.g., to 9
to 11 dpf). In all, we observed the delayed non-neuronal
repression phenotype - early non-neural expression of
reporter which then fades with time - in 14 of 32 (44%)
NRSE enhancer trap lines. Nevertheless, when character-
ized between 6 and 11 dpf, the majority of enhancer trap
lines presented a neural-restricted expression phenotype.
Changes in REST expression are correlated with delayed
transgene repression
NRSF/REST expression is complex, displaying stage- and
neuronal cell-type specific expression patterns and splice
variants that reflect a diversity of roles in regulating gene
expression. In zebrafish, NRSF/REST expression has only
been characterized through early embryonic stages where
it is expressed fairly ubiquitously throughout the nervous
system until downregulated in differentiating ventrolateral
domains of the central nervous system [57]. This pattern
is somewhat inconsistent with the early neural expression
we observed in the majority of neural-restricted enhancer
trap lines (Additional file 4). However, because REST pro-
tein levels are modulated post-translation [58,59], protein
expression domains may not correlate well with mRNA
expression domains. Nevertheless, our data are consistent
with the possibility that NRSF/REST may also play a role
in activating expression in discrete neural cell subtypes, as
suggested in studies of the REST4 isoform in the mouse
[60]. Another possible explanation would be that the
repressive function of NRSF/REST requires a threshold of
expression. This might also explain the delayed repression
phenotype seen in some NRCK enhancer trap lines (see
Figure 4). To address this question we evaluated NRSF/
REST mRNA expression levels by qRT-PCR from 6 h to 7
dpf. Interestingly, expression levels increased approxi-
mately two-fold at 6 dpf (Figure 5A, B), coinciding with
the time we see evidence of reporter loss in non-neural
cells in lines displaying delayed repression. It is also possi-
ble the repressive function of NRSF/REST requires
co-factors that are not expressed until later stages of devel-
opment. Finally, subcellular localization changes [61,62]
alter NRSF/REST function during development as well.
To provide more clarity on this issue, we used morpholino
knockdown and zinc finger nuclease targeting [38] to
determine whether NRSF/REST expression was required
for early neural expression and/or the delayed non-neural
repression phenotypes.
NRSE-mediated transgene repression is dependent on
NRSF/REST expression
To determine if NRSF/REST expression is required for
NRSE-mediated effects on transgene expression, we evalu-
ated the delayed repression phenotype following disrup-
tion of NRSF/REST expression. A splice junction targeted
morpholino-modified oligonucleotide (MO) against zebra-
fish rest mRNA [57] was injected into NRCK; 14xNTR-
Ch; 5xMY-HMY triple transgenic eggs displaying the
Xie et al. BMC Biology 2012, 10:93
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delayed reporter loss phenotype (gmc607). Comparisons
among uninjected control, control MO and rest MO-
injected larvae showed clear differences in reporter expres-
sion (Figure 6). Uninjected (Figure 6A-D) and control
MO-injected (Figure 6E-H) larvae displayed the expected
delayed repression phenotype, with loss of muscle expres-
sion over time. By contrast, the number of muscle cells
expressing reporter proteins appeared to be increased at
Figure 4 Delayed repression of non-neural transgene expression. (A-H) Representative time series confocal images of 4- and 7-dpf transgenic
larvae showing gradual loss of reporter expression from non-neural tissues; a common phenotype of NRSE-delimited Gal4-VP16 driver lines. (A-D)
Time series of a triple transgenic larva from a cross between an NRSE-delimited Gal4-VP16 (KalTA4) driver line (NRCK gmc607), an mCherry reporter
line (Tg(14xUAS:nfsb-mCherry)c264), and a pan-neuronal marker for neuronal expression, Tg(elavl3:EGFP)knu3 line (formerly HuC:GFP [56]). Image
magnifications of bordered regions in A and C show skeletal muscle expression fading over time (B and D, arrows), while neuronal expression is
maintained (B and D, arrowheads). Expression within the gut (dashed line) is an enteric neuron subpopulation; note 100% overlap with the pan-
neural elavl3:GFP reporter (co-expressing cells appears yellow). (E-H) Time series of a double transgenic larva from a cross between an NRSE-
delimited Gal4-VP16 (KalTA4) driver line (NRCK gmc607) and the YFP-expressing reporter line (5xMY-HMY gmc930). Image magnifications of
bordered regions in E and G show skeletal muscle expression also fades over time when driver lines are crossed to YFP reporter lines (F and H,
arrows), thus this phenomenon is not a result of NRSE-independent silencing of the reporter (as has been shown for the Tg(14xUAS:nfsb-mCherry)
c264 line [48,49]). YFP expression typically takes longer to decay than mCherry, possibly due to stronger basal expression and/or absence of
methylation due to the reduced number of UAS elements [49] or barrier insulator sequences. Note that the membrane-tagged YFP reporter
improves visualization of axonal and dendritic neuronal outgrowths, e.g., the labeled enteric neuron subpopulation in the gut.
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3 dpf in larvae injected with rest MO (Figure 6I, J). In
addition, muscle cell reporter expression was maintained
in rest MO-injected larvae at 6 and 9 dpf (Figure 6K, L),
well after the sparse muscle expression evident in 3-dpf
control larvae had dissipated. As an additional control, rest
MO injections had no effect on transgene expression
when enhancer trap lines without NRSE insertions were
tested (i.e., CK;5xMY-HMY double transgenic lines). The
number of larvae expressing the mCherry reporter in mus-
cle cells at 6 dpf was quantified across all three conditions
(Figure 6M). A total of 96% (44 out of 46) of the rest MO
group continued to express detectable reporter in muscle
cells, whereas only 11% (6 out of 54) in the uninjected and
8% (3 out of 37) in control MO groups did so. Further-
more, when the number of muscle cells expressing repor-
ter protein at 3, 6 and 9 dpf was quantified from all
imaged larvae, rest MO-injected larvae showed clear
increases in muscle cell expression compared to controls
(Figure 6N, O). These results strongly suggest that REST
expression is required to repress non-neural expression of
NRSE-containing transgenes. This same trend held for 1-
μM and 2-μM MO-injection experiments over a total of
seven independent MO assays. Similar results were
obtained from analyses of NRCK transgenic lines crossed
into a newly characterized rest mutant background [38].
Together, these studies show NRSE/RE1 sequences pro-
mote neural-specific transgene expression in a NRSF/
REST-dependent manner.
Discussion
We have explored the use of tissue-specific silencer ele-
ments to delimit transgene expression to a region of
interest by repressing transcription elsewhere. This strat-
egy provides a potential means of eliminating unintended
expression (e.g., cryptic background patterns) and/or
undesirable expression (e.g., fine-tuning promoters that
target desired cell types as well as other tissues). In parti-
cular, we tested whether inserting NRSE sites into
Figure 5 qRT-PCR analysis of developmental REST expression. (A) Electrophoresis gel of RT-PCR products showing relative levels of REST
(top) and b-actin (bottom) expression at 12 hours post-fertilization and then daily from 1 to 7 dpf. (B) Graph showing normalized REST
expression levels relative to b-actin controls as assayed by qRT-PCR. This analysis shows that REST expression increases significantly at 6 dpf, a
time point correlated with reductions in skeletal muscle expression in NRSE-containing enhancer trap lines. Relative expression analyses were
performed using 2-ΔΔCT methods; the experiment was repeated a total of three times, with averages and standard deviations shown per time
point.
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upstream regulatory regions of Gal4-VP16 driver and/or
UAS-based reporter constructs (Additional file 1) would
serve to delimit transgene expression to the nervous sys-
tem. We found that inclusion of tandem NRSE sites
strongly biased the expression of Gal4-VP16 driver trans-
genes to the nervous system (Figures 1 and 2) but did not
restrict expression when associated solely with UAS
reporter transgenes (Figure 3). Nevertheless, due to the
binary nature of the Gal4/UAS system, restricting Gal4-
VP16 driver expression is sufficient to limit UAS-linked
effector/reporters to Gal4-VP16 expression domains
when the two components are brought together (Figures
1 and 2, summarized in Figure 7). Thus, although NRSE-
UAS vectors do not appear adequate to alter existing
Gal4-VP16 resources, new NRSE-Gal4-VP16 lines can be
derived to provide an improved resource for manipulat-
ing neural tissues. By providing improved spatial control
over molecules that manipulate neural cell function (e.g.,
dominant-negatives, optogenetic tools, etc), NRSE-delim-
ited toolsets will enhance the capacity to ascribe cause
and effect relationships to cellular and/or molecular
function.
Adaptation of the Gal4/UAS system to the zebrafish sys-
tem [37] was initially met with great enthusiasm due to
the versatile and powerful nature of bipartite transgene
expression systems. However, this effort soon became
fraught with problematic issues, such as low expressivity,
Gal4-VP16 toxicity and, more recently, methylation-based
Figure 6 NRSE-delimited transgene expression is REST dependent. A-L show representative time series confocal images at 3, 6 and 9 dpf of
NRCK; 14xNTR-Ch; 5xMY-HMY triple transgenic larvae ± rest morpholino (MO) injection. (A-D) Uninjected control larvae showed the delayed
repression phenotype of NRCK line gmc607, where early skeletal muscle expression (A, B, arrows) fades over time (C, D). Note that loss of the YFP
reporter is delayed relative to the mCherry reporter. (E-H) Control MO-injected larvae display the same phenotype as uninjected controls with
muscle expression (E, F, arrows) fading over time (G, H). (I-L) Conversely, rest MO-injected larvae have an expansion of skeletal muscle expression
at day 3 (I, K, arrows) that fails to be repressed with time (K, L, arrows). (M-O) Quantification of phenotypes between uninjected, control MO, and
rest MO-injected larvae; the number of larvae with detectable mCherry expression in muscle cells at 6 dpf was increased for rest morphants
(green bar) relative to controls (M, asterisk P < 0.01). The number of mCherry (N) and YFP expressing (O) muscle cells also increased for rest
morphants (green bars) relative to uninjected (blue bars) and MO controls (red bars) at all time points (N, asterisks P ≤ 0.01, number symbols P <
0.05; O, asterisks P < 0.001, number symbols P < 0.05). Morpholinos were injected at 0.25, 0.5, 1 and 2 μM with similar results (data from
representative 0.5-μM injections is shown, experiment was repeated six times). Statistical comparisons were performed using an independent
sample t-test to compare across treatment conditions per time point (asterisks), and a repeated measures t-test to compare individual samples
to their initial values at 3 dpf (number signs).
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Figure 7 Summary. Schematic summarizing our findings regarding NRSE-delimited transgene expression within the context of bipartite driver
(B) and effector/reporter lines (C). In each panel, the driver transgene (e.g., Gal4-based) is at the top and the reporter/effector (e.g., UAS) is at the
bottom. Transgene products Gal4 and Cherry are shown as circles and ovals, respectively. (A) In the absence of NRSE sites, bipartite driver
systems are prone to broad non-specific expression patterns with evidence of so-called background expression in skeletal muscle and heart (see
Figures 1 and 2). (B) Associating NRSE sites with effector/reporter transgenes is not sufficient to restrict transgene expression to the nervous
system (see Figure 3), possibly due to an inability to overcome enhanced transcriptional activity typical of artificial bipartite drivers (e.g., Gal4-
VP16). (C) Incorporating NRSE sites into driver transgenes serves to bias expression toward neuronal specific patterns (see Figures 1 and 2). These
findings suggest that creating novel associations between regulatory activators (e.g., enhancers) and silencer elements (e.g., NRSE sites) is a
useful strategy for attaining tissue-specific expression patterns that extend beyond what can be obtained with standard transgenesis techniques.
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transgene silencing of UAS reporter lines. Solutions to
these problems have been developed [43,49,63,64], as well
as strategies for Gal4-VP16-based lineage tracing [43].
However, a general lack of cell-specific expression of many
of the Gal4-VP16 driver lines generated to date presents
an obstacle to the widespread deployment of such
resources. Efforts to address this issue have included the
development of a miniTol2 cassette [44], characterizations
of alternative minimal promoters [10,43,64,65], the use of
gene traps as opposed enhancer traps [8], and modulating
Gal4 expression through interactions with Gal80 [14,66].
We reasoned that an alternative strategy would be to
leverage tissue-specific silencer elements to delimit trans-
gene expression to tissue types of interest by eliminating
expression in non-targeted regions. More specifically, we
were interested in a strategy that would enhance the neu-
ronal specificity of transgene expression, thus facilitating
exciting new functional assay platforms such as optoge-
netics [67].
It remains unclear whether the background patterns evi-
dent in Gal4-VP16 lines are predominantly an artifact
(e.g., cryptic enhancers), promiscuous position effects,
Gal4-VP16 based amplification of previously undetectable
gene/enhancer activity [14], or a combination of these.
Interestingly, the latter possibility is in keeping with sto-
chastic resonance analyses suggesting many genes are
active at low levels as part of natural circadian oscillations
[68]. In addition, Fujimoto et al., favored this explanation
regarding unexpected but consistent expression patterns
seen in multiple Tg(optb.A:Gal4-VP16) lines [14]. Com-
bined with data presented here, this would suggest that
NRSE sites are capable of delimiting endogenous enhan-
cers, not simply reducing an artificial byproduct of the
technique. Unfortunately, due to inherent ambiguities of
identifying distinct regulatory elements acting on gene/
enhancer traps [69,70], the transgenic lines generated here
can provide only limited insight to this question. Never-
theless, the data show that regardless of the mechanism,
NRSE sites serve to bias enhancer traps toward neuronal
specific expression patterns, thus providing useful new
resources for neurobiological research.
The addition of NRSE sites to UAS reporter lines was
not sufficient to restrict reporter expression to neural tis-
sues (Figures 3 and 7, Table 1). This is unfortunate, as
NRSE-delimited UAS lines would have been useful to
restrict the expression of existing Gal4-VP16 lines. How is
it that NRSE sites can function to alter the expression of
Gal4-based enhancer traps but not UAS reporter lines?
The answer to this may be related to the fact that NRSE
sites only served to bias expression; they were not 100%
effective. This is in keeping with our increasing under-
standing of the complex multifactorial nature of gene reg-
ulation. Transcriptional activity cannot be adequately
described in binary on/off terms; rather each element
impinging on gene expression provides relative ‘rheostat’-
type modulations that are summed for final effect. Accord-
ingly, our data suggest that, the majority of the time,
REST/NRSE interactions are adequate to dampen non-
neural expression when integrated with endogenous regu-
latory elements. Thus, in the context of an enhancer trap
screen, REST/NRSE interactions are sufficient to reduce
Gal4-VP16 expression to non-effective levels in non-
neural populations. However, when non-neural expression
of Gal4-VP16 is unchecked - i.e., when NRSE sites are
solely associated with UAS reporters - the artificially
enhanced strength of Gal4-VP16 transcriptional activators
is the dominant element in the equation and the silencing
activity of REST/NRSE is rendered ineffective.
Our findings indicate that new NRSE -delimited Gal4-
VP16 driver lines will need to be derived to take advantage
of the neural expression bias provided by this approach.
Accordingly, we have begun a large-scale NRSE-delimited
enhancer trap screen to create new Gal4-VP16 lines useful
for dissecting neural circuit functions. To date, 62 NRSE-
delimited KalTA4-expressing lines have been created. In a
related screen, we are creating a series of NRSE-delimited
LexA-based driver lines (manuscript in preparation). The
use of two bipartite transgene expression systems (e.g.,
Gal4/UAS and LexA/LexA Operon) would allow two neu-
ronal subpopulations to be independently manipulated.
Optimally, complementary platforms of this nature could
be used to differentially modulate pre- and post-synaptic
elements of discrete subcircuits - a possibility that
improved trans-synaptic transporters would facilitate. In
addition, the use of an inducible LexA-based transactiva-
tion system in transgenic zebrafish [71] provides an addi-
tional level of temporal control over transgene expression;
a strategy that increases the versatility of such systems
even further.
The mechanism behind NRSE-delimited transgene
expression is likely due to a repressive action of NRSF/
REST in non-neural tissues [3,4]. Our data are consistent
with this; a possible explanation for the reduction in non-
neural phenotypes we see with NRSE lines (Figure 1S) is
that, at some frequency, lines that would have expressed
solely in non-neural cells are rendered silent by NRSE.
However, context-dependent transcriptional regulatory
functions have been proposed for NRSF/REST that span
the gamut of embryogenesis: from embryonic stem cells
[72], to neural progenitors [26], to differentiating neurons
[28,73]. In neural lineages, NRSF/REST is thought to
repress gene expression in progenitors until differentiation
commences. In agreement with these models, REST
expression levels decrease over time in neural lineages
[26,58,59]. Conversely, NRSF/REST is thought to repress
neural gene expression in non-neural cells, in keeping
with NRSF/REST expression becoming progressively
restricted to non-neural tissues as development proceeds.
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Thus, REST may play several roles during development,
including repression of neuronal genes in the developing
nervous system and later non-neuronal cells, and regula-
tion of the terminal differentiation of neurons (reviewed
by [74,75]). Several of our observations are in keeping with
the view that REST action is more complex than simply
repressing expression in non-neural cells; however, our
data are not consistent with REST playing a major role in
regulating neurogenesis [38].
REST is expressed nearly ubiquitously during early zeb-
rafish development, including within the nervous system.
Yet, early reporter expression (e.g., 1 to 2 dpf) is observed
in the majority of NRSE-containing Gal4-VP16 driver
lines (Additional file 4). This observation conflicts some-
what with reports suggesting that REST acts to repress
neural differentiation programs in stem cells [72] and/or
neuronal progenitors [26], which predicts that NRSE-
delimited transgene expression would be limited to late
neural differentiation stages. However, because NRSF/
REST translation is tightly regulated [26,58,59], evalua-
tions of REST protein expression levels and/or subcellular
localization are necessary to better determine the degree
to which REST expression patterns correlate to function.
In addition, almost half of the NRSE-containing driver
lines established to date (44%) show delayed non-neural
repression of transgene expression (Figure 4). The timing
of the delayed repression phenomenon is associated with a
nearly two-fold increase in REST expression (Figure 5);
this suggests that REST-mediated silencing requires a
threshold of expression. This possibility is supported by
data showing a two-fold increase in REST expression that
coincides with downregulation of NRSE-containing neuro-
nal genes in differentiating oligodendrocytes [76], and a
corresponding increase in the number of REST-occupied
target genes in these cells as they mature [77]. Addition-
ally, our results are consistent with data from Kok et al.,
showing that early neural patterning is largely unaltered in
rest mutants [38].
It is important to note that lines displaying the delayed
repression phenotype will be less useful for experiments
concerning early neural development. However, their
applicability to tests in late stage larvae (6 dpf) and
beyond - for instance, to assay behavioral consequences
of altering neuronal activity - remains viable.
To further test whether REST was required for NRSE-
delimited expression patterns, we knocked down REST
expression in transgenic NRCK zebrafish embryos and lar-
vae using a previously characterized morpholino. The data
showed clear evidence that when REST function is dis-
rupted, NRSE-mediated neural expression biases are lost,
with spatially expanded and temporally extended strong
skeletal muscle expression seen in rest MO-injected
NRSE-containing Gal4-VP16 driver lines (Figure 6). In
addition, investigations of a rest mutant line (restsbu29),
generated by zinc finger nuclease targeting [78,79], showed
similar results with four different NRCK transgenic lines
(gmc606, 607, 632 and 641) [38]. Interestingly, evidence of
expanded neural expression in restsbu29/sbu99 mutants sug-
gests REST can repress expression in the nervous system
as well. This is in keeping with studies suggesting that
REST may act to repress gene expression in neuronal sub-
sets [28] and that REST expression is detected in neurons
of certain brain regions [73]. More recently, the possibility
of REST acting as a transcriptional activator has been
attributed to the expression of a dominant-negative splice
variant, REST4, that disrupts REST-mediated gene repres-
sion [80]. Future analyses could determine whether the
presence of REST4 alters the expression of NRSE-contain-
ing transgenes.
Cell-type specific lineages are often defined by multi-
factorial ‘codes’ of overlapping subsets of transcription
factors [81]. Thus, identifying individual promoter/
enhancer elements providing cell-type exclusive expres-
sion patterns can be challenging. A potential strategy
suggested by the data presented here is to create artificial
associations between tissue-specific silencer elements
and regulatory elements that target cell types of interest,
albeit not exclusively. By eliminating expression in non-
targeted tissues, the silencer element serves to produce
the desired expression pattern; e.g., a cell-specific expres-
sion domain that might not otherwise be attainable. As
an example of this approach, we are creating neuronally
restricted Gal4-VP16 driver transgenic lines. These
resources should facilitate the functional dissection of
neural circuits in zebrafish - e.g., optogenetic [82] and/or
toxin-mediated inhibition/activation of neuronal activity
[8], and inducible cell ablations [46,83-85] - by restricting
manipulations to targeted neuronal cell subpopulations,
thus facilitating delineations of causal relationships.
Conclusions
These studies validate the use of tissue-specific silencer
elements to promote enhanced transgene expression spe-
cificity. NRSE sites served to bias the expression of trapped
and defined DNA regulatory elements to the nervous sys-
tem, providing a means of targeting neuronal cell subtypes
by silencing expression in non-neural tissues. Transgene
silencing effects were dependent on the expression of
REST, in keeping with a well-characterized role of this
NRSE-binding transcriptional repressor in maintaining
neural-specific gene expression. Using the strategy, pro-
moter/enhancer elements that would otherwise be too
broadly expressed can be harnessed for functional assays.
This approach also affords a solution to non-specific back-
ground expression issues that can compromise large-scale
enhancer trap screens, as has been the case in the zebra-
fish field. NRSE-delimited transgenes can provide useful
new tools for functional studies of the nervous system.
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Inclusion of bipartite expression systems, such as Gal4/
UAS, ensures that a multitude of functional assays can be
performed with NRSE-delimited transgenic resources. For
instance, integrating new toolsets for manipulating neuro-
nal activity or targeted cellular ablation systems into bipar-
tite effectors will provide a versatile platform for the
genetic dissection of neural circuit function. More broadly,
similar genetic mechanisms may be used to reinforce
expression specificity in other tissues. Thus, creating syn-
thetic associations between endogenous regulatory
sequences and tissue-specific silencer elements could pro-
vide a means of targeting unique cellular subsets for which
cell-specific regulatory elements are lacking.
Methods
Ethics statement
This study was carried out in accordance with the
recommendations in the Guide for the Care and Use
of Laboratory Animals of the National Institutes of
Health. An animal use protocol was approved by the
Institutional Animal Care and Use Committee
(Approval Identification Number: BR10-12-391) of
Georgia Health Sciences University, which has an Ani-
mal Welfare Assurance on file in the Office of Labora-
tory Animal Welfare (Assurance Number: A3307-01).
Using approved anesthetics, all efforts were made to
minimize discomfort and suffering during experimental
procedures.
Zebrafish husbandry, transgenes and transgenic lines
Zebrafish were maintained using established temperature
(28.5°C) and light cycle conditions (14 hours on, 10 hours
off). Embryos and larvae were cultured in standard growth
media supplemented with paramecia and Sera micron
flake (Sera; Heinsberg, Germany) starting at 5 dpf. Pre-
viously described transgenic zebrafish strains used in this
study included Tg(elavl3:EGFP)knu3 [56] and Tg(14xUAS-
E1b:nfsB-mCherry)c264 [45].
Transgenes used to establish new transgenic lines dur-
ing the course of these studies are diagrammed in Addi-
tional file 1. New transgenic lines include four different
types of enhancer trap driver lines (two sets, ±NRSE)
expressing an optimized Gal4-VP16 fusion, termed
KalTA4 [43]; two motor neuron targeted (i.e., zCREST1
enhancer [35]) lines based on two multicistronic self-
reporting Gal4/UAS plasmids; and two 5xUAS-based
YFP reporter lines based on two different plasmids
(±NRSE sequences). Two control transgenes that did not
contain NRSE sites were used to establish enhancer trap
lines, designated CK (Et(cfos:KalTA4)) and CK-5xN-14xY
(Et(cfos:KalTA4, 5xUAS-E1b:nfsB, 14xUAS-E1b:tagYFP)).
Two NRSE-containing transgenes were used to create
new NRSE-delimited enhancer trap lines, designated
NRCK (Et(2xNRSE-cfos:KalTA4)) and NRCK-5xMY (Et
(2xNRSE-cfos:KalTA4,loxP- 5xUAS-E1b:gap43-YFP-
loxP)). CREST1 enhancer containing transgenes were
used to make lines designated C1CK-5xY2N (Tg
(CREST1- cfos:KalTA4,5xUAS-E1b:gap43-tagYFP-2A-
nfsB)) and NR C1CK-5xY2N (Tg(2xNRSE-CREST1- cfos:
KalTA4,5xUAS-E1b:gap43-tagYFP-2A-nfsB)). In the
CREST1 lines, a ‘self-cleaving’ viral peptide sequence,
derived from porcine teschovirus-1 (P2A [86]), was used
to promote equimolar expression of a bicistronic message
[87] consisting of a YFP reporter and nitroreductase
[51,88] (i.e., YFP-2A-nfsB). A non-NRSE 5xUAS-based
reporter transgene was used to make a reporter line
designated 5xMY-HMY (Tg(loxP-5xUAS-E1b:gap43-YFP-
loxP, he1a:gap43-YFP)gmc830). In addition, a NRSE-con-
taining 5xUAS-based reporter transgene was used to
make a reporter line designated NR5xMY-HMY (Tg
(loxP-2xNRSE-5xUAS-E1b:gap43-YFP-loxP, he1a:gap43-
YFP)gmc835). All transgenes were assembled in the mini-
Tol2 background to facilitate transgenesis efficiency [44].
A set of core cloning vectors were synthesized (Gen-
Script; Piscataway, New Jersey, USA, or BioMatik;
Wilmington, Delaware, USA) from which all transgenes
were constructed. This was done to optimize codon
usage (i.e., ‘zebrafish-ize’ codons), eliminate GC content
where possible, incorporate elements promoting
improved transgene stability, and provide unique cloning
sites allowing functional subunits to be easily exchanged.
UAS reporter transgenes generated by our laboratory
were flanked by an AT-rich ‘barrier’ insulator sequence
thought to separate methylated and unmethylated
domains near CpG islands [50]. This was done in an effort
to circumvent variegated transgene expression resultant to
methylation-induced silencing of UAS-based transgenic
lines in zebrafish, specifically demonstrated to effect
expression of the Tg(14xUAS:nfsb-mCherry)c264 line
[48,49]. Most coding sequences were followed by a rabbit
b-globin intron sequence shown to improve viral and
transgene expression efficiency [89] that was previously
evaluated for the ability to promote mRNA stability and
nuclear export of KalTA4 transgenes [43]. Finally, a trans-
gene ‘tracer’ strategy was used to facilitate identification of
UAS reporter transgene carriers in the absence of Gal4-
VP16 expression. A 365 bp promoter of the zebrafish
hatching enzyme 1a (he1a), which contained three regions
highly conserved between he1a, he1b and he2, was used to
drive expression of membrane-tagged YFP (i.e., he1a:
gap43-YFP) in the hatching gland, a set of cells located
within the yolk sac that are resorbed after hatching. This
allows UAS reporter carriers to be identified by a ‘tempor-
ary tracer’ that fades by 4 dpf, thus does not impinge on
late larval imaging experiments (see Additional file 5),
unlike similar strategies using heart- and lens-specific
Xie et al. BMC Biology 2012, 10:93
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promoters that are expressed into adulthood. Complete
transgene sequences and cloning details are available upon
request. Stable lines were established in the roy orbison
(roy) pigmentation mutant background with Tol2-based
transgenesis methods.
RNA isolation and real-time qRT-PCR analysis
Ten wild-type embryos were collected at the indicated
developmental stages and total RNA was isolated using
TRIzol (Life Technologies; Grand Island, New York, USA)
according to the manufacturer’s protocol and treated with
DNase (Promega; Madison, Wisconsin, USA) to remove
genomic DNA contamination. The first-strand cDNA
synthesis was performed using the SuperScript II First-
Strand System (Life Technologies; Grand Island, New
York, USA). qRT-PCR reactions were carried out as
described previously [90,91]. In brief, cDNA amplification
was performed in triplicate using the Bio-Rad iQ SYBR
Green Supermix (Bio-Rad; Hercules, California, USA) on a
Bio-Rad iCycler (Bio-Rad; Hercules, California, USA).
Gene expression levels were normalized to b-actin by 2-
ΔΔCT methods. The primers used in this study were as
follows: b-actin: forward 5’- CGAGCAGGAGATGGG
AACC - 3’; reverse 5’- CAACGGAAACGCTCATTGC -
3’; REST: forward 5’- GAGAGCGCAGAGAGCAACTC -
3’; reverse 5’- GCGCAGATGGTGCACTTGAA - 3’.
Disruption of NRSF/REST expression
To knock down REST production, a previously charac-
terized splice inhibiting morpholino targeted to the
intron-exon boundary of zebrafish rest exon 3 (5’-
GGCCTTTCACCTGTAAAATACAGAA-3’) was used.
The control morpholino was the standard provided by
GeneTools (5’-CCTCTTACCTCAGTTACAATTTATA-
3’; Philomath, Oregon, USA). Morpholinos were diluted
to 0.1, 0.25, 0.5, 1 or 2 μM and a 1- to 2-nL volume
injected into eggs as previously described [90]. Images
from a 0.1-μM injection are shown in Figure 6. Zinc fin-
ger nuclease targeting of the rest locus was as previously
described [38].
Confocal imaging
All single time point and time lapse confocal imaging of
transgenic zebrafish larvae was performed as previously
described [83].
Statistical analyses
Statistical comparisons were performed using an inde-
pendent sample t-test to compare across treatment con-
ditions, or a repeated measures t-test for time series
data; i.e., when data from individuals were compared
across time. Where symbols are present in figures, P-
values were minimally ≤ 0.05.
Additional material
Additional file 1: Diagram of transgene constructs. Schematics
showing pertinent details of the transgenes tested and corresponding
acronyms. Core elements include: cfos - minimal promoter [34]; KalTA4 -
an optimized Gal4-VP16 fusion protein [43]; GI - rabbit beta-globin intron
to promote mRNA stability [89]; pA - SV40 or bovine growth hormone
polyadenylation sequences; 2xNRSE - a tandem repeat of a 21 bp
consensus NRSE site [33], lox - loxP recombination sites to allow
transgene cassette swapping [92]; UAS - 17 bp upstream activator
sequence [63] specific for the Gal4 DNA binding domain (with indicated
number of repeats, e.g., 5x or 14x); E1b - a basal promoter from carp
beta-actin [37]; CREST1 - a 800-bp enhancer element characterized as a
cranial motor neuron-specific element [35]; 2A - a porcine 2A viral
peptide sequence [86] promoting equimolar expression of multicistronic
messages [87]; nfsB - Escherichia coli gene encoding the prodrug
converting bacterial enzyme nitroreductase (Ntr) which promotes
chemically-induced cell ablation [52,53,88]; HE - a 365-bp promoter
element from the zebrafish hatching enzyme 1a locus (he1a) that allows
facile detection of UAS reporter lines in the absence of Gal4-VP16 driver
elements (see Additional file 5). Fluorescent reporters included: M-YFP -
a membrane-tagged (dual palmitoylation sequence from the Xenopus
gap43 locus [93] ‘enhanced’ yellow fluorescent protein (EYFP); M-tYFP - a
membrane-tagged (same as above) monomeric ‘tag’ yellow fluorescent
protein (tagYFP); mCherry - a monomeric red fluorescent protein [94].
Additional file 2: Enhancer trap comparisons ±NRSE. Confocal images
of an additional 12 NRCK (left box) and 6 CK (right box) lines are shown
in support of the phenotypic data summarized in Figure 1S. Each line is
designated by a transgenic allele number (e.g., gmc601) and with the
phenotypic characterization (e.g., Neural, Mixed, Non-Neural) provided in
the lower right of each image set. Additional high resolution imaging
data is available on line at [47].
Additional file 3: High-resolution imaging of branchiomotor neuron
labeling. (A-E) Confocal images of 6-dpf NRC1CK-5xY2N transgenic line
(Tg(2xNRSE-CREST1-cfos:KalTA4, 5xUAS-E1b:YFP-2A-nfsB)lmc003) showing
specific labeling of branchiomotor neuron ganglia. When NRSE sites were
placed upstream of CREST1-cfos, expression became restricted to cranial
motor neuron subpopulations; the expression pattern originally
characterized as CREST1-specified [35]. (B, C) Motor ganglia expression
included cranial nerve X (vagus, arrow in hindbrain region), VII (facial,
down arrowhead), anterior and posterior V (trigeminal, up arrowhead); IV
and III (trochlear and oculomotor, respectively, right arrowhead). (D, E)
Unidentified descending spinal nerve.
Additional file 4: Early neuronal expression of NRSE Gal4 driver
transgenes. Confocal images of 2-dpf triple transgenic line (Et(2xNRSE-
cfos:KalTA4) gmc607; Tg(14xUAS:nfsB-mCherry)c264; Tg(elavl3:EGFP)knu3)
showing typical early neural expression (arrows indicate double labeled
neuronal cells) of NRCK lines (NRSE Gal4 drivers).
Additional file 5: Hatching enzyme promoter-based transgene
‘tracer’. Stereoscope micrograph shows expression of he1a:YFP ’tracer’
transgene in 1-dpf embryos. This element allows transgenic UAS reporter
lines (e.g., Tg(loxP-5xUAS-E1b:gap43-YFP-loxP, he1a:gap43-YFP)gmc830,
shown here) to be visually sorted from non-transgenic siblings (asterisks)
at embryonic to early larval stages in the absence of Gal4 driver
expression. The 365 bp he1a promoter is robustly active (arrow) from 1
to 3 dpf, after which expression rapidly fades. Inclusion of this element in
UAS reporter lines has greatly simplified maintenance of our stocks.
Abbreviations
2A: a porcine 2A viral peptide sequence; 2xNRSE: a tandem repeat of a 21
bp consensus NRSE site; 5xMY-HMY: Tg(loxP-5xUAS-E1b:gap43-YFP-loxP: he1a:
gap43-YFP) transgene or transgenic reporter line (e.g.: allele number
gmc930); 5xUAS: transgene sequence composed of five serial repeats of UAS
binding sites; 14xNTR-Ch: 14xUAS-E1b:nfsB-mCherry)c264 transgenic line; bp:
base pairs; C1CK-5xY2N: Tg(CREST1- cfos:KalTA4:5xUAS-E1b:gap43-tagYFP-2A-
nfsB) transgene or transgenic line (allele number lmc002); cfos: minimal
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promoter element from mouse cFos gene; CK: Tg(cfos:KalTA4) transgene or
transgenic lines (allele numbers gmc675-gmc699); CK-5xN-14xY: Et(2xNRSE-
cfos:KalTA4: 5xUAS-E1b:nfsB: 14xUAS-E1b:tagYFP) transgene or enhancer trap
transgenic lines (allele numbers gmc700-gmc724); CREST1: highly conserved
enhancer element from the zebrafish Islet-1 gene; dpf: days post-fertilization;
E1b: basal promoter from carp beta-actin; Gal4: yeast transcription activator
protein; Gal4/UAS: a bipartite transgene expression amplification system;
Gal4-VP16: fusion protein linking the DNA binding domain of Gal4 and
transcriptional activation domain of VP16; KalTA4: Gal4-VP16 fusion variant
optimized for expression in zebrafish; lox: loxP recombination site; MO:
morpholino-modified oligonucleotide; M-YFP: membrane-tagged yellow
fluorescent protein; nfsB: bacterial gene encoding nitroreductase B; NR5xMY-
HMY: Tg(2xNRSE-loxP-5xUAS-E1b:gap43-YFP-loxP: he1a:gap43-YFP) transgene or
transgenic reporter line (e.g.: allele number gmc932); NRC1CK-5xY2N: Tg
(2xNRSE-CREST1- cfos:KalTA4:5xUAS-E1b:gap43-tagYFP-2A-nfsB) transgene or
transgenic line (e.g.: allele number lmc003); NRCK: Et(2xNRSE-cfos:KalTA4)
transgene or enhancer trap transgenic lines (allele numbers gmc600-
gmc674); NRCK-5xMY: Et(2xNRSE-cfos:KalTA4: 5xUAS-E1b:gap43-YFP) transgene
or enhancer trap transgenic lines (allele numbers gmc725-gmc774); NRSE:
neuron-restrictive silencer element; NRSF: neuron-restrictive silencing factor;
qRT-PCR: quantitative reverse transcriptase polymerase chain reaction; RE1:
restriction element 1; REST: RE1-silencing transcription factor; STMN2:
stathmin-like 2 gene (aka SCG10); Tol2: a member of the hAT family of
transposons; UAS: upstream activating sequence; VP16: viral protein 16, a
strong transcriptional activator; YFP: yellow fluorescent protein.
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